Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.97
-0.30
(-5.69%)
USD |
NASDAQ |
Oct 13, 11:15
Corbus Pharmaceuticals Holdings Price : 4.97 for Oct. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 5.35 | 5.402 | 5.11 | 5.27 | 1.011M |
| Oct 09, 2026 | 5.25 | 5.610 | 5.171 | 5.38 | 872798.0 |
| Oct 08, 2026 | 5.80 | 5.80 | 5.130 | 5.27 | 1.346M |
| Oct 07, 2026 | 5.72 | 5.795 | 5.47 | 5.49 | 1.242M |
| Oct 06, 2026 | 5.87 | 5.995 | 5.65 | 5.78 | 707588.0 |
| Oct 05, 2026 | 6.17 | 6.17 | 5.83 | 5.85 | 793491.0 |
| Oct 02, 2026 | 6.59 | 6.68 | 6.06 | 6.13 | 835403.0 |
| Oct 01, 2026 | 6.80 | 6.82 | 6.25 | 6.34 | 802994.0 |
| Sep 30, 2026 | 6.75 | 6.88 | 6.57 | 6.82 | 508287.0 |
| Sep 29, 2026 | 6.93 | 7.05 | 6.59 | 6.63 | 786179.0 |
| Sep 28, 2026 | 7.12 | 7.18 | 6.88 | 6.92 | 932060.0 |
| Sep 25, 2026 | 7.50 | 7.590 | 6.97 | 7.14 | 708578.0 |
| Sep 24, 2026 | 7.69 | 7.76 | 7.125 | 7.45 | 757963.0 |
| Sep 23, 2026 | 7.83 | 7.98 | 7.66 | 7.74 | 787819.0 |
| Sep 22, 2026 | 7.73 | 7.95 | 7.61 | 7.875 | 453845.0 |
| Sep 21, 2026 | 7.51 | 7.79 | 7.42 | 7.65 | 499816.0 |
| Sep 18, 2026 | 7.22 | 7.67 | 7.154 | 7.48 | 1.155M |
| Sep 17, 2026 | 7.26 | 7.38 | 7.03 | 7.26 | 992867.0 |
| Sep 16, 2026 | 6.86 | 7.50 | 6.82 | 7.26 | 1.229M |
| Sep 15, 2026 | 8.08 | 8.08 | 6.325 | 6.92 | 3.757M |
| Sep 14, 2026 | 7.93 | 8.70 | 7.66 | 8.08 | 8.396M |
| Sep 11, 2026 | 8.38 | 8.495 | 7.95 | 8.12 | 2.347M |
| Sep 10, 2026 | 8.75 | 8.79 | 8.21 | 8.24 | 646758.0 |
| Sep 09, 2026 | 10.60 | 10.72 | 8.845 | 8.86 | 1.004M |
| Sep 08, 2026 | 11.07 | 11.07 | 10.31 | 10.60 | 915463.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.84 |
| Alnylam Pharmaceuticals, Inc. | 225.23 |
| Anika Therapeutics, Inc. | 20.53 |
| Savara, Inc. | 4.89 |
| Vericel Corp. | 40.66 |
Price Related Metrics
| PEG Ratio | -0.0272 |
| Price to Book Value | 0.9076 |
| Earnings Yield | -124.3% |
| Market Cap | 92.80M |
| PEGY Ratio | -0.0272 |